Correlation Between Oncopeptides and Clavister Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncopeptides and Clavister Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and Clavister Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncopeptides AB and Clavister Holding AB, you can compare the effects of market volatilities on Oncopeptides and Clavister Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of Clavister Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and Clavister Holding.

Diversification Opportunities for Oncopeptides and Clavister Holding

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Oncopeptides and Clavister is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and Clavister Holding AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clavister Holding and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with Clavister Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clavister Holding has no effect on the direction of Oncopeptides i.e., Oncopeptides and Clavister Holding go up and down completely randomly.

Pair Corralation between Oncopeptides and Clavister Holding

Assuming the 90 days trading horizon Oncopeptides AB is expected to under-perform the Clavister Holding. But the stock apears to be less risky and, when comparing its historical volatility, Oncopeptides AB is 1.03 times less risky than Clavister Holding. The stock trades about -0.27 of its potential returns per unit of risk. The Clavister Holding AB is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  154.00  in Clavister Holding AB on August 29, 2024 and sell it today you would earn a total of  38.00  from holding Clavister Holding AB or generate 24.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Oncopeptides AB  vs.  Clavister Holding AB

 Performance 
       Timeline  
Oncopeptides AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Clavister Holding 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Clavister Holding AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Clavister Holding may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Oncopeptides and Clavister Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncopeptides and Clavister Holding

The main advantage of trading using opposite Oncopeptides and Clavister Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, Clavister Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clavister Holding will offset losses from the drop in Clavister Holding's long position.
The idea behind Oncopeptides AB and Clavister Holding AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Correlations
Find global opportunities by holding instruments from different markets